Partner Investment Management, L.P. - Q2 2014 holdings

$499 Million is the total value of Partner Investment Management, L.P.'s 64 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 63.9% .

 Value Shares↓ Weighting
AGN BuyALLERGAN INC$26,592,000
+243.0%
157,144
+151.6%
5.32%
+272.3%
VMC BuyVULCAN MATLS CO$26,267,000
+104.9%
412,039
+113.6%
5.26%
+122.4%
HOT BuySTARWOOD HOTELS&RESORTS WRLD$26,054,000
+4.8%
322,374
+3.3%
5.22%
+13.8%
MLM BuyMARTIN MARIETTA MATLS INC$24,941,000
+159.4%
188,877
+152.1%
4.99%
+181.5%
RAD BuyRITE AID CORP$24,316,000
+1610.0%
3,391,372
+1395.8%
4.87%
+1758.4%
NFLX NewNETFLIX INC$20,472,00046,464
+100.0%
4.10%
HCA SellHCA HOLDINGS INC$19,328,000
-21.1%
342,820
-26.5%
3.87%
-14.3%
FOXA BuyTWENTY FIRST CENTY FOX INCcl a$18,306,000
+24.1%
520,783
+12.9%
3.66%
+34.7%
WAG SellWALGREEN CO$17,831,000
-2.9%
240,533
-13.5%
3.57%
+5.4%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDadr$17,775,000
+8.2%
339,085
+9.1%
3.56%
+17.5%
B108PS SellACTAVIS PLC$16,707,000
-18.6%
74,901
-24.9%
3.34%
-11.6%
MCK BuyMCKESSON CORP$15,613,000
+101.6%
83,846
+91.1%
3.13%
+118.8%
PCLN BuyPRICELINE GRP INC$14,856,000
+143.7%
12,349
+141.4%
2.98%
+164.4%
ADBE NewADOBE SYS INC$13,863,000191,588
+100.0%
2.78%
PANW NewPALO ALTO NETWORKS INC$12,923,000154,119
+100.0%
2.59%
VRX BuyVALEANT PHARMACEUTICALS INTL$11,598,000
+18.2%
91,963
+23.5%
2.32%
+28.3%
FB BuyFACEBOOK INCcl a$11,422,000
+176.8%
169,749
+147.9%
2.29%
+200.5%
MDVN BuyMEDIVATION INC$11,274,000
+1650.6%
146,260
+1361.1%
2.26%
+1796.6%
AAP NewADVANCE AUTO PARTS INC$10,926,00080,980
+100.0%
2.19%
A BuyAGILENT TECHNOLOGIES INC$10,025,000
+4.4%
174,532
+1.7%
2.01%
+13.3%
MIC BuyMACQUARIE INFRASTR CO LLCmembership int$9,887,000
+45.8%
158,529
+33.9%
1.98%
+58.3%
SBUX NewSTARBUCKS CORP$9,138,000118,094
+100.0%
1.83%
SAVE BuySPIRIT AIRLS INC$9,056,000
+6813.0%
143,208
+6394.7%
1.81%
+7454.2%
AXP BuyAMERICAN EXPRESS CO$8,587,000
+42.7%
90,514
+35.4%
1.72%
+54.9%
CTRP BuyCTRIP COM INTL LTD$8,353,000
+56.6%
130,441
+23.3%
1.67%
+70.0%
GILD SellGILEAD SCIENCES INC$8,196,000
-33.2%
98,851
-42.9%
1.64%
-27.5%
MSFT NewMICROSOFT CORP$8,161,000195,718
+100.0%
1.63%
MHFI SellMCGRAW HILL FINL INC$7,685,000
-27.0%
92,556
-33.0%
1.54%
-20.8%
HAL SellHALLIBURTON CO$7,549,000
-54.1%
106,309
-61.9%
1.51%
-50.1%
TIBX NewTIBCO SOFTWARE INC$7,526,000373,135
+100.0%
1.51%
SCHW SellSCHWAB CHARLES CORP NEW$5,960,000
-61.9%
221,330
-61.3%
1.19%
-58.7%
NOW SellSERVICENOW INC$5,476,000
-28.8%
88,372
-31.1%
1.10%
-22.7%
CBS SellCBS CORP NEWcl b$5,380,000
-35.0%
86,579
-35.4%
1.08%
-29.5%
BIDU NewBAIDU INCspon adr rep a$5,021,00026,877
+100.0%
1.00%
GOOGL SellGOOGLE INCcl a$4,896,000
-85.5%
8,374
-72.4%
0.98%
-84.3%
TEX SellTEREX CORP NEW$4,675,000
-38.1%
113,751
-33.3%
0.94%
-32.9%
BuyDENDREON CORPnote 2.875% 1/1$4,220,000
-4.4%
5,953,000
+0.2%
0.84%
+3.8%
CYH NewCOMMUNITY HEALTH SYS INC NEW$4,183,00092,206
+100.0%
0.84%
PHM NewPULTE GROUP INC$3,054,000151,480
+100.0%
0.61%
VNET New21VIANET GROUP INCsponsored adr$2,706,00090,297
+100.0%
0.54%
GOOG NewGOOGLE INCcl c$2,303,0004,003
+100.0%
0.46%
ACAD BuyACADIA PHARMACEUTICALS INC$1,386,000
-7.2%
61,372
+0.0%
0.28%
+1.1%
KYTH SellKYTHERA BIOPHARMACEUTICALS I$1,388,000
-11.4%
36,173
-8.2%
0.28%
-3.8%
HNT SellHEALTH NET INC$1,297,000
-73.1%
31,215
-78.0%
0.26%
-70.7%
KPTI BuyKARYOPHARM THERAPEUTICS INC$1,160,000
+209.3%
24,922
+105.1%
0.23%
+236.2%
OREX SellOREXIGEN THERAPEUTICS INC$1,066,000
-46.2%
172,518
-43.4%
0.21%
-41.8%
THC SellTENET HEALTHCARE CORP$1,027,000
-47.4%
21,878
-52.1%
0.21%
-42.8%
HUM SellHUMANA INC$825,000
-51.5%
6,457
-57.2%
0.16%
-47.5%
TMO SellTHERMO FISHER SCIENTIFIC INC$798,000
-88.3%
6,765
-88.0%
0.16%
-87.2%
MOH SellMOLINA HEALTHCARE INC$716,000
-37.6%
16,034
-47.5%
0.14%
-32.5%
ANAC SellANACOR PHARMACEUTICALS INC$708,000
-12.5%
39,929
-1.2%
0.14%
-4.7%
CLVS SellCLOVIS ONCOLOGY INC$692,000
-87.9%
16,714
-79.8%
0.14%
-86.8%
OCR SellOMNICARE INC$680,000
+9.3%
10,220
-2.0%
0.14%
+18.3%
IPXL NewIMPAX LABORATORIES INC$609,00020,295
+100.0%
0.12%
BRKR SellBRUKER CORP$570,000
-10.7%
23,487
-16.1%
0.11%
-3.4%
RPRX SellREPROS THERAPEUTICS INC$563,000
-28.1%
32,535
-26.2%
0.11%
-21.5%
ALDR NewALDER BIOPHARMACEUTICALS INC$560,00027,893
+100.0%
0.11%
MDCO NewMEDICINES CO$526,00018,097
+100.0%
0.10%
AEGR NewAEGERION PHARMACEUTICALS INC$406,00012,637
+100.0%
0.08%
VSAR NewVERSARTIS INC$398,00014,199
+100.0%
0.08%
RVNC SellREVANCE THERAPEUTICS INC$303,000
-23.7%
8,919
-29.2%
0.06%
-16.4%
MYL NewMYLAN INC$290,0005,626
+100.0%
0.06%
CLDN  CELLADON CORP$244,000
+34.8%
15,2220.0%0.05%
+48.5%
RCPT NewRECEPTOS INC$116,0002,717
+100.0%
0.02%
TEVA ExitTEVA PHARMACEUTICAL INDS LTDcall$0-15,900
-100.0%
-0.00%
MYGN ExitMYRIAD GENETICS INC$0-1,609
-100.0%
-0.01%
CSLT ExitCASTLIGHT HEALTH INCcl b$0-3,777
-100.0%
-0.02%
PKI ExitPERKINELMER INC$0-4,572
-100.0%
-0.04%
MGNX ExitMACROGENICS INC$0-8,211
-100.0%
-0.04%
BLUE ExitBLUEBIRD BIO INC$0-11,454
-100.0%
-0.05%
FRX ExitFOREST LABS INC$0-3,269
-100.0%
-0.06%
CI ExitCIGNA CORPORATION$0-6,659
-100.0%
-0.10%
TXMD ExitTHERAPEUTICSMD INC$0-94,772
-100.0%
-0.11%
CX ExitCEMEX SAB DE CVspon adr new$0-51,444
-100.0%
-0.12%
PRTA ExitPROTHENA CORP PLC$0-21,273
-100.0%
-0.15%
ICPT ExitINTERCEPT PHARMACEUTICALS IN$0-2,612
-100.0%
-0.16%
ACOR ExitACORDA THERAPEUTICS INC$0-28,385
-100.0%
-0.20%
PFE ExitPFIZER INC$0-47,354
-100.0%
-0.28%
APC ExitANADARKO PETE CORP$0-24,409
-100.0%
-0.38%
DATA ExitTABLEAU SOFTWARE INCcl a$0-41,712
-100.0%
-0.58%
YELP ExitYELP INCcl a$0-41,658
-100.0%
-0.59%
EXPE ExitEXPEDIA INC DEL$0-55,767
-100.0%
-0.75%
CRM ExitSALESFORCE COM INC$0-108,923
-100.0%
-1.15%
LBTYK ExitLIBERTY GLOBAL PLC$0-200,613
-100.0%
-1.51%
YHOO ExitYAHOO INC$0-284,047
-100.0%
-1.88%
WYNN ExitWYNN RESORTS LTD$0-53,916
-100.0%
-2.21%
TWC ExitTIME WARNER CABLE INC$0-99,499
-100.0%
-2.52%
WDAY ExitWORKDAY INCcl a$0-153,578
-100.0%
-2.59%
ENDP ExitENDO INTL PLC$0-218,033
-100.0%
-2.76%
BMY ExitBRISTOL MYERS SQUIBB CO$0-754,383
-100.0%
-7.23%
EEM ExitISHARESmsci emg mkt etf$0-1,195,800
-100.0%
-9.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC25Q4 20191.9%
HCA HOLDINGS INC23Q4 20195.4%
HUMANA INC22Q4 20193.5%
EDWARDS LIFESCIENCES CORP21Q4 20193.7%
CLOVIS ONCOLOGY INC20Q3 20186.6%
UNITEDHEALTH GROUP INC19Q4 20195.0%
MEDICINES CO19Q3 20183.0%
AERIE PHARMACEUTICALS INC18Q4 20193.1%
SALESFORCE COM INC17Q3 20192.7%
NETFLIX INC17Q2 20195.6%

View Partner Investment Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-NT2020-11-16
13F-NT2020-08-14
13F-NT2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-13
13F-HR2018-08-14

View Partner Investment Management, L.P.'s complete filings history.

Compare quarters

Export Partner Investment Management, L.P.'s holdings